Ouabain increases myofibrillar Ca2+ sensitivity but does not influence the Ca2+ release in human skinned fibres

Eur J Pharmacol. 2004 May 25;492(2-3):225-31. doi: 10.1016/j.ejphar.2004.03.064.

Abstract

The present study investigated the impact of the Na(+) pump inhibitor ouabain (g-strophanthin) on Ca(2+) sensitivity and Ca(2+) release in human right auricular trabeculae (coronary bypass) and in skinned muscle fibres from left ventricular myocardium (cardiac transplantation, dilated cardiomyopathy). A time-dependent increase in force of contraction was observed in right auricular trabeculae in response to ouabain (100 nM) before the intracellular Ca(2+) transient (fura-2) increased (n=6). In triton X-skinned fibres (no sarcoplasmic reticulum) of human failing myocardium, ouabain (1-100 nM) concentration-dependently increased tension at a free extracellular Ca(2+) concentration of 1 microM and the Hill coefficient of the Ca(2+)-dependent tension development. Ouabain (1-100 nM) did not directly induce a Ca(2+) release out of the sarcoplasmic reticulum, nor did it alter the caffeine (10 mM) induced sarcoplasmic reticulum Ca(2+) release in saponin-skinned fibre preparations in which the sarcoplasmic reticulum had been Ca(2+)-loaded. In conclusion, ouabain increases myofibrillar Ca(2+) sensitivity possibly due to an increase in the cooperativity of the thick and thin myofilaments. This mechanism may additionally contribute to the positive inotropic effect of ouabain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Caffeine / pharmacology
  • Calcium / metabolism*
  • Female
  • Humans
  • In Vitro Techniques
  • Isometric Contraction / drug effects
  • Male
  • Middle Aged
  • Muscle Fibers, Skeletal / drug effects*
  • Muscle Fibers, Skeletal / physiology
  • Myocardial Contraction / drug effects
  • Myocardium / metabolism
  • Myofibrils / drug effects*
  • Myofibrils / physiology
  • Ouabain / pharmacology*
  • Sarcoplasmic Reticulum / drug effects
  • Sarcoplasmic Reticulum / metabolism
  • Sodium-Potassium-Exchanging ATPase / antagonists & inhibitors*
  • Stimulation, Chemical
  • Time Factors
  • Ventricular Dysfunction, Left / metabolism
  • Ventricular Dysfunction, Left / physiopathology

Substances

  • Caffeine
  • Ouabain
  • Sodium-Potassium-Exchanging ATPase
  • Calcium